The assessment of serious cancerous tumors (e.g., Wilms’ tumor or gonadoblastoma in patients with WT1 mutations) can be potentially possible through genetic diagnostic tests for the primary analysis and disease monitoring of certain extra-renal phenotypes [53]. Here, WT1 is linked to gonadoblastoma.